Quantum Cyber Launches $100 Million At-The-Market Offering With Titan Partners Securities

Quantum Cyber (QUCY) initiated a $100 million at-the-market equity offering via Titan Partners Securities. Proceeds will fund product development, expansion, acquisitions, and general corporate purposes, according to the company's SEC filing.

Original reporting
Published Oct 9, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Quantum Cyber Launches $100 Million At-The-Market Offering With Titan Partners Securities — source image
Decision brief

The 30-second read

$QUCYBearishMed
01

Why it matters

A $100 million ATM authorization typically signals the company wants flexible capital for development and expansion, but it also introduces potential share dilution over the execution window.

02

Market read

Traders may reassess dilution risk, financing runway, and near-term supply overhang for QUCY following the new ATM authorization.

03

What to watch

No details are given on expected issuance pace, pricing mechanism, or whether the company has near-term catalysts that could absorb dilution.

Relevance 7/10Novelty 7/10Timing: signed Oct 9, 2026, effective same day

Background

The company filed an 8-K describing an at-the-market equity offering sales agreement, enabling it to sell ordinary shares from time to time.

Company-level read

Ticker impact

$QUCYBearishMedium confidence
Context

Quantum Cyber entered an at-the-market equity offering sales agreement for up to $100 million, with Titan Partners as sales agent.

Expected impact

Likely near-term pressure as dilution risk is priced, partially offset by funding for growth initiatives.

Evidence & confidence

The article discloses a fresh $100 million ATM framework and intended use of proceeds, but provides no pricing, timing, or expected share issuance schedule.

Market effects

May increase attention on small-cap/early-stage equity issuance risk and financing conditions for growth-oriented software/cyber names.

Limited, primarily affects Nasdaq-listed Quantum Cyber and its peer financing sentiment.

Low, no cross-market policy or macro linkage described.

Counterpoint

ATM programs can be executed opportunistically when liquidity and valuation are favorable, limiting dilution impact versus a fixed-price secondary.

Key entities

  • Quantum Cyber N.V.

    Nasdaq-listed issuer that entered an ATM equity offering sales agreement for up to $100 million.

  • Titan Partners Securities

    Sales agent for the at-the-market equity offering.

Related articles

$QUCYMed

Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter…

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter 2026 Form 10-Q Highlights: ● Four customers each accounting for 10% or more of quarterly revenue, with no single

$QUCYMed

Quantum Cyber N.V. (QUCY) Appoints Maj. Gen. Rosende to Board

Quantum Cyber N.V. (QUCY) added Maj. Gen. (Ret.) Alberto C. Rosende to its board to oversee its Bridgeport, CT facility and supply chain for autonomous drones. The move supports the company's focus on domestic, vertically integrated manufacturing to meet U.S. demand, which could become a revenue catalyst if milestones are met.

$QUCYLow

Quantum Cyber N.V. (QUCY): Completion of Acquisition or Disposition of Assets

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0001874252 00-0000000 0001874252 2026-07-15 2026-07-15 0001874252 dei:FormerAddressMember 2026-07-15 2026-07-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Sect

$ORCLMed

Oracle says OpenAI infrastructure deal is fully funded after final capital raise

Oracle announced its infrastructure deal with OpenAI is fully funded after a $20B capital raise. Shares rose 3.3% in after-hours trading. The company plans to expand data-center capacity, including a 4.5GW project in the US. Oracle confirmed financing is in place, with additional vendor discussions as options. The Abilene campus, where OpenAI’s GPT-6 Astra was trained, is nearly complete.

$SXTPHighAI 9/10

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On November 19, 2026, 60 Degrees Pharmaceuticals, Inc.…

60 DEGREES PHARMACEUTICALS, INC. (SXTP) filed an SEC Form 8-K — Other Events. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On November 19, 2026, 60 Degrees Pharmaceuticals, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Na